| 03/09/20 | 15:15:16 | 3 Sept 2020 | | Hikma receives favourable court ruling | RNS |
| 02/09/20 | 09:30:05 | 2 Sept 2020 | | Total Voting Rights | RNS |
| 07/08/20 | 07:00:05 | 7 Aug 2020 | | Half-year Report | RNS |
| 03/08/20 | 14:25:22 | 3 Aug 2020 | | Total Voting Rights | RNS |
| 16/07/20 | 12:06:27 | 16 Jul 2020 | | Notice of Results | RNS |
| 07/07/20 | 12:48:19 | 7 Jul 2020 | | Publication of Offering Circular | RNS |
| 25/06/20 | 16:12:49 | 25 Jun 2020 | | Holding(s) in Company | RNS |
| 25/06/20 | 13:00:12 | 25 Jun 2020 | | Directorate Change | RNS |
| 23/06/20 | 11:39:03 | 23 Jun 2020 | | Holding(s) in Company | RNS |
| 23/06/20 | 07:00:05 | 23 Jun 2020 | | Transaction in Own Shares | RNS |
| 22/06/20 | 17:13:11 | 22 Jun 2020 | | Transaction in Own Shares | RNS |
| 22/06/20 | 11:24:11 | 22 Jun 2020 | | Director/PDMR Shareholding | RNS |
| 22/06/20 | 11:22:22 | 22 Jun 2020 | | Director/PDMR Shareholding | RNS |
| 22/06/20 | 11:20:07 | 22 Jun 2020 | | Director/PDMR Shareholding | RNS |
| 02/06/20 | 09:31:58 | 2 Jun 2020 | | Total Voting Rights | RNS |
| 22/05/20 | 07:00:08 | 22 May 2020 | | Hikma receives FDA approval for generic Vascepa® | RNS |
| 20/05/20 | 15:42:40 | 20 May 2020 | | Director/PDMR Shareholding | RNS |
| 13/05/20 | 13:28:02 | 13 May 2020 | | Director/PDMR Shareholding | RNS |
| 01/05/20 | 11:30:02 | 1 May 2020 | | Total Voting Rights | RNS |
| 30/04/20 | 12:00:01 | 30 Apr 2020 | | Result of AGM | RNS |
| 30/04/20 | 07:00:08 | 30 Apr 2020 | | Directorate Change | RNS |
| 30/04/20 | 07:00:06 | 30 Apr 2020 | | Trading Statement | RNS |
| 16/04/20 | 15:07:23 | 16 Apr 2020 | | Director/PDMR Shareholding | RNS |
| 14/04/20 | 14:30:43 | 14 Apr 2020 | | Block listing Interim Review | RNS |
| 02/04/20 | 08:00:04 | 2 Apr 2020 | | AGM Update | RNS |
| 31/03/20 | 08:00:07 | 31 Mar 2020 | | Hikma's favourable ruling in generic Vascepa® | RNS |
| 24/03/20 | 10:52:28 | 24 Mar 2020 | | Director/PDMR Shareholding | RNS |
| 19/03/20 | 12:00:04 | 19 Mar 2020 | | Annual Financial Report | RNS |
| 28/02/20 | 12:27:28 | 28 Feb 2020 | | Director/PDMR Shareholding | RNS |
| 28/02/20 | 12:26:47 | 28 Feb 2020 | | Director/PDMR Shareholding | RNS |
| 28/02/20 | 12:23:22 | 28 Feb 2020 | | Director/PDMR Shareholding | RNS |
| 27/02/20 | 16:40:01 | 27 Feb 2020 | | Director/PDMR Shareholding | RNS |
| 27/02/20 | 16:35:01 | 27 Feb 2020 | | Board Committee Changes | RNS |
| 27/02/20 | 07:05:03 | 27 Feb 2020 | | Hikma enters agreement to commercialise Ryaltris™ | RNS |
| 27/02/20 | 07:00:09 | 27 Feb 2020 | | Final Results | RNS |
| 04/02/20 | 14:06:58 | 4 Feb 2020 | | Total Voting Rights | RNS |
| 04/02/20 | 09:07:54 | 4 Feb 2020 | | Notice of Results | RNS |
| 15/01/20 | 09:46:22 | 15 Jan 2020 | | Director/PDMR Shareholding | RNS |
| 15/01/20 | 09:44:06 | 15 Jan 2020 | | Director/PDMR Shareholding | RNS |
| 13/01/20 | 08:00:01 | 13 Jan 2020 | | Hikma announces agreement with Chiesi Group | RNS |
| 09/01/20 | 08:00:04 | 9 Jan 2020 | | Hikma announces agreement with Arecor | RNS |
| 02/01/20 | 10:56:31 | 2 Jan 2020 | | Total Voting Rights | RNS |
| 10/12/19 | 12:06:02 | 10 Dec 2019 | | Civica Rx and Hikma announce shipment of medicines | RNS |
| 27/11/19 | 07:00:03 | 27 Nov 2019 | | Hikma completes FDA response for generic Advair® | RNS |
| 21/11/19 | 14:47:40 | 21 Nov 2019 | | Director/PDMR Shareholding | RNS |
| 08/11/19 | 11:17:11 | 8 Nov 2019 | | Block Listing Application | RNS |
| 07/11/19 | 07:00:06 | 7 Nov 2019 | | Trading Statement | RNS |
| 05/11/19 | 09:34:31 | 5 Nov 2019 | | Total Voting Rights | RNS |
| 04/10/19 | 14:36:00 | 4 Oct 2019 | | Holding(s) in Company | RNS |
| 01/10/19 | 16:15:15 | 1 Oct 2019 | | Block listing Interim Review | RNS |
